Year: 2013
Type: review
Abstract: According to the classical incretin con-cept, glucagon-like peptide (GLP)-1is viewed as a hormone produced in the intestinal L cells and acting via the circulation on satiety in the brain, gut motility, and insulin and glucagon secretion in the pancreatic islet. How-ever, in contrast to typical hormones, plasma levels of GLP-1 are relatively low with a very short half-life. Furthermore, GLP-1 is rapidly inactivated by dipep-tidyl peptidase-4 (DPP-4) in the vicinity of L cells within,1 min from the secre-tion of the gut peptide (1,2). This rapid metabolism of GLP-1 raises questions about how its effects are mediated on target organs such as pancreatic b-cells.
Source: Diabetes Care
DOI: 10.2337/dcs13-2015
Authors: Marc Y. Donath, Rémy Burcelin
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2100904495
